NZ217821A
(en)
*
|
1985-10-10 |
1989-07-27 |
Biotech Australia Pty Ltd |
Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
|
US5672334A
(en)
*
|
1991-01-16 |
1997-09-30 |
Access Pharmaceuticals, Inc. |
Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
|
US5707604A
(en)
*
|
1986-11-18 |
1998-01-13 |
Access Pharmaceuticals, Inc. |
Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
|
US5807832A
(en)
*
|
1987-06-09 |
1998-09-15 |
Biotech Australia Pty Limited |
Oral delivery of biologically active substances bound to vitamin B12
|
AU628403B2
(en)
*
|
1988-09-29 |
1992-09-17 |
Access Pharmaceuticals, Inc. |
Methods and compositions for magnetic resonance imaging
|
US5260050A
(en)
*
|
1988-09-29 |
1993-11-09 |
Ranney David F |
Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
|
US5213788A
(en)
*
|
1988-09-29 |
1993-05-25 |
Ranney David F |
Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
|
US5997856A
(en)
*
|
1988-10-05 |
1999-12-07 |
Chiron Corporation |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
|
US5527527A
(en)
*
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5672683A
(en)
*
|
1989-09-07 |
1997-09-30 |
Alkermes, Inc. |
Transferrin neuropharmaceutical agent fusion protein
|
US5977307A
(en)
*
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
US6329508B1
(en)
|
1989-09-07 |
2001-12-11 |
Alkermes, Inc. |
Transferrin receptor reactive chimeric antibodies
|
US5154924A
(en)
*
|
1989-09-07 |
1992-10-13 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5182107A
(en)
*
|
1989-09-07 |
1993-01-26 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
CA2069635C
(en)
*
|
1989-11-27 |
1998-05-05 |
Junzo Seki |
Fat emulsion
|
US5227372A
(en)
*
|
1990-03-07 |
1993-07-13 |
Children's Medical Center Corporation |
Method for retaining ophthalmological agents in ocular tissues
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
US6989141B2
(en)
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
IN172208B
(de)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
US7083778B2
(en)
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
JPH0776175B2
(ja)
*
|
1990-04-26 |
1995-08-16 |
サイトアーレクス・コーポレーシヨン |
損傷されたかまたは病気になった組織の局所的処置用の組成物および方法
|
US5216130A
(en)
*
|
1990-05-17 |
1993-06-01 |
Albany Medical College |
Complex for in-vivo target localization
|
US6159502A
(en)
*
|
1991-04-02 |
2000-12-12 |
Biotech Australia Pty Ltd |
Oral delivery systems for microparticles
|
AU707085B2
(en)
*
|
1991-04-02 |
1999-07-01 |
Access Pharmaceuticals Australia Pty Limited |
Oral delivery systems for microparticles
|
US5605938A
(en)
*
|
1991-05-31 |
1997-02-25 |
Gliatech, Inc. |
Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
|
US5705178A
(en)
*
|
1991-05-31 |
1998-01-06 |
Gliatech, Inc. |
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
|
GB9119762D0
(en)
*
|
1991-09-16 |
1991-10-30 |
Filler Aaron G |
Particulate agents for nmt
|
IL104084A
(en)
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
FR2687071B1
(fr)
*
|
1992-02-10 |
1995-06-23 |
Exsymol Sa |
Vecteur pour principe(s) actif(s) therapeutique(s) ou cosmetique(s) a usage externe et composition therapeutique ou cosmetique comprenant un tel vecteur.
|
US5474765A
(en)
*
|
1992-03-23 |
1995-12-12 |
Ut Sw Medical Ctr At Dallas |
Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
|
WO1994002183A1
(en)
*
|
1992-07-27 |
1994-02-03 |
Haemacure Biotech Inc. |
Biocompatible surgical implant
|
DK0656368T4
(da)
*
|
1992-08-05 |
2003-09-29 |
Meito Sangyo Kk |
Kompositmateriale med lille diameter, som indeholder et vandopløseligt carboxypolysaccharid og magnetisk jernoxid
|
JPH08506319A
(ja)
*
|
1992-10-08 |
1996-07-09 |
ヴァレリ ユ. アラホフ |
ミセル中に組み込まれた抗−新生物性組成物
|
US5362425A
(en)
*
|
1992-10-22 |
1994-11-08 |
Technology Unlimited, Inc. |
Organic oil spray-drying techniques
|
BR9405798A
(pt)
*
|
1993-02-22 |
1995-12-12 |
Vivorx Pharmaceuticals Inc |
Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
EP0684814B1
(de)
*
|
1993-02-22 |
1998-06-17 |
Alza Corporation |
Mittel zur oralen gabe von wirkstoffen
|
US5997904A
(en)
*
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
ATE156706T1
(de)
*
|
1993-03-17 |
1997-08-15 |
Silica Gel Gmbh |
Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben
|
GB9312315D0
(en)
*
|
1993-06-15 |
1993-07-28 |
Poston Robin |
Leukocyte adhesion assay
|
DE69427251T2
(de)
*
|
1993-07-27 |
2001-10-31 |
Terumo Corp |
Verabreichungssystem für Arzneistoffe
|
US5798091A
(en)
|
1993-07-30 |
1998-08-25 |
Alliance Pharmaceutical Corp. |
Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
|
WO1995003835A1
(en)
|
1993-07-30 |
1995-02-09 |
Alliance Pharmaceutical Corp. |
Stabilized microbubble compositions for ultrasound
|
US5633003A
(en)
*
|
1994-03-31 |
1997-05-27 |
Cantor; Jerome O. |
Use of intratracheally administered hyaluronic acid to ameliorate emphysema
|
AUPM572294A0
(en)
*
|
1994-05-18 |
1994-06-09 |
Vaccine Technologies Pty. Ltd. |
Delivery vehicle for bioactive molecule
|
WO1996004922A1
(en)
*
|
1994-08-10 |
1996-02-22 |
Davis, Joanne, T. |
Method of using hyaluronic acid for the detection, location and diagnosis of tumors
|
FR2723849B1
(fr)
|
1994-08-31 |
1997-04-11 |
Biovector Therapeutics Sa |
Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique
|
US5540909A
(en)
*
|
1994-09-28 |
1996-07-30 |
Alliance Pharmaceutical Corp. |
Harmonic ultrasound imaging with microbubbles
|
US6015555A
(en)
*
|
1995-05-19 |
2000-01-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
EP0832446A1
(de)
*
|
1995-06-07 |
1998-04-01 |
The Regents Of The University Of California |
Therapeutische mikrovorrichtungen, verfahren zur herstellung und verwendung derselben
|
US6107102A
(en)
*
|
1995-06-07 |
2000-08-22 |
Regents Of The University Of California |
Therapeutic microdevices and methods of making and using same
|
US5804162A
(en)
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US6106866A
(en)
*
|
1995-07-31 |
2000-08-22 |
Access Pharmaceuticals, Inc. |
In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
|
CA2235036A1
(en)
|
1995-11-08 |
1997-05-15 |
University Of South Florida |
Guinea pig model for leiomyomas and atherosclerosis
|
WO1997025073A2
(en)
|
1996-01-10 |
1997-07-17 |
Nycomed Imaging A/S |
Contrast media
|
GB9600427D0
(en)
*
|
1996-01-10 |
1996-03-13 |
Nycomed Imaging As |
Contrast media
|
US5855868A
(en)
*
|
1996-04-01 |
1999-01-05 |
Nycomed Imaging As |
Method of T1 -weighted resonance imaging of RES organs
|
CA2252374C
(en)
|
1996-04-19 |
2007-08-07 |
Alpha Therapeutic Corporation |
A process for viral inactivation of lyophilized blood proteins
|
EP1369111A1
(de)
*
|
1996-10-03 |
2003-12-10 |
Hermes Biosciences, Inc. |
Hydrophile Mikropartikel und Verfahren zu deren Herstellung
|
US6096291A
(en)
*
|
1996-12-27 |
2000-08-01 |
Biovector Therapeutics, S.A. |
Mucosal administration of substances to mammals
|
DE69841984D1
(de)
*
|
1997-09-05 |
2010-12-16 |
Maruho K K |
Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
|
US6489306B2
(en)
|
1998-02-23 |
2002-12-03 |
University Of South Florida |
Method of intranasal gene transfer for protection against respiratory infection
|
US6028102A
(en)
*
|
1998-02-24 |
2000-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticonvulsant drugs and pharmaceutical compositions thereof
|
US6338834B1
(en)
|
1998-04-30 |
2002-01-15 |
The Curators Of The University Of Missouri |
Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
|
US6391861B1
(en)
|
1998-05-14 |
2002-05-21 |
The Trustees Of Columbia University In The City Of New York |
Method for the prevention of tissue elastic fiber injury
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(en)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
US7002003B1
(en)
|
1998-07-30 |
2006-02-21 |
University Of South Florida |
Method for the inhibition of function of STAT transcription factors
|
US6780397B2
(en)
|
1998-09-01 |
2004-08-24 |
Curators Of The University Of Missouri |
Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
|
US6379691B1
(en)
|
1998-09-29 |
2002-04-30 |
Medtronic/Ave, Inc. |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
US6299980B1
(en)
|
1998-09-29 |
2001-10-09 |
Medtronic Ave, Inc. |
One step lubricious coating
|
US6409987B1
(en)
|
1999-04-07 |
2002-06-25 |
Intimax Corporation |
Targeted agents useful for diagnostic and therapeutic applications
|
US6638974B1
(en)
|
1999-04-09 |
2003-10-28 |
University Of South Florida |
Ascorbyl esters for the treatment of cancer
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7655423B2
(en)
*
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
EP1233670B1
(de)
*
|
1999-06-14 |
2008-09-17 |
Henry Ford Health System |
Stickstoffmonoxid-donoren zum induzieren von neurogenese
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US6462066B2
(en)
|
1999-12-02 |
2002-10-08 |
University Of South Florida |
Method and composition for treatment of ischemic neuronal reperfusion injury
|
EP1292314A2
(de)
*
|
2000-05-23 |
2003-03-19 |
The Trustees of Columbia University in the City of New York |
Methode zur behandlung von krankheiten der atemwege durch einsatz von glycosaminoglycane
|
WO2002003921A2
(en)
*
|
2000-07-11 |
2002-01-17 |
University Of South Florida |
Bax fragment induced tumor cell death
|
US6803060B2
(en)
|
2000-09-07 |
2004-10-12 |
Joe Reyes |
Composition to boost libido
|
US20060194242A1
(en)
*
|
2000-10-27 |
2006-08-31 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US20070025958A1
(en)
*
|
2000-10-27 |
2007-02-01 |
Hadden John W |
Vaccine immunotherapy
|
CA2464228C
(en)
*
|
2000-10-27 |
2017-01-17 |
Immuno-Rx, Inc. |
Vaccine immunotherapy for immune suppressed patients
|
US20070154399A1
(en)
*
|
2000-10-27 |
2007-07-05 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US7182942B2
(en)
*
|
2000-10-27 |
2007-02-27 |
Irx Therapeutics, Inc. |
Vaccine immunotherapy for immune suppressed patients
|
US20070031372A1
(en)
*
|
2004-08-05 |
2007-02-08 |
Hadden John W |
Vaccine immunotherapy for immune suppressed patients
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
US7172770B2
(en)
*
|
2001-02-19 |
2007-02-06 |
Board Of Regents, The University Of Texas System |
Mesoporous compositions for use in drug delivery
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
CA2498591A1
(en)
|
2001-10-26 |
2003-05-01 |
Immuno-Rx, Inc. |
Immunotherapy for reversing immune suppression
|
DE60304945T2
(de)
*
|
2002-07-16 |
2007-01-04 |
Seiko Epson Corp. |
Mikrokapselhaltige Zusammensetzung für elektrophoretische Anzeigen
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
WO2005021065A2
(en)
*
|
2003-08-29 |
2005-03-10 |
New York University |
Indirect delivery of growth factors into the central nervous system
|
EP1663283B1
(de)
*
|
2003-09-12 |
2012-05-23 |
University of Colorado |
Glutamin zur verwendung bei der behandlung von verletzungen
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
JP4755113B2
(ja)
|
2004-01-30 |
2011-08-24 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
線維性状態およびその他の疾患の治療のための、オリゴリボヌクレオチドおよびその使用方法
|
US7741299B2
(en)
|
2004-08-16 |
2010-06-22 |
Quark Pharmaceuticals, Inc. |
Therapeutic uses of inhibitors of RTP801
|
BRPI0516177B8
(pt)
|
2004-09-28 |
2021-05-25 |
Quark Biotech Inc |
oligorribonucleotídeos, uso dos mesmos, uso de um composto sirna eficaz para inibir 0 p53 humano e composição farmacêutica que os contém, bem como método para diminuição da expressão do gene p53
|
JPWO2006035550A1
(ja)
*
|
2004-09-28 |
2008-05-15 |
国立大学法人大阪大学 |
三次元誘導装置及び方法、並びに薬剤配送システム
|
WO2007080129A1
(en)
|
2006-01-13 |
2007-07-19 |
A Chan Holding B.V. |
Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
|
DOP2007000015A
(es)
|
2006-01-20 |
2007-08-31 |
Quark Biotech Inc |
Usos terapéuticos de inhibidores de rtp801
|
US20080260678A1
(en)
*
|
2006-10-10 |
2008-10-23 |
University Of Colorado |
Molecular band-aid
|
JP2010507387A
(ja)
|
2006-10-25 |
2010-03-11 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
新規のsiRNAおよびその使用方法
|
US8729121B2
(en)
|
2007-06-25 |
2014-05-20 |
Adhezion Biomedical, Llc |
Curing accelerator and method of making
|
WO2010008822A2
(en)
|
2008-06-23 |
2010-01-21 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
|
ES2474176T3
(es)
|
2007-06-27 |
2014-07-08 |
Quark Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir la expresión de genes pro-apopt�ticos
|
RU2487716C2
(ru)
|
2007-10-03 |
2013-07-20 |
Кварк Фармасьютикалс, Инк. |
Новые структуры малых интерферирующих рнк (sirna)
|
US8613952B2
(en)
*
|
2007-11-14 |
2013-12-24 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives
|
US8486528B2
(en)
*
|
2008-01-22 |
2013-07-16 |
Gwangju Institute Of Science And Technology |
Temperature-sensitive nano-carriers
|
EP2106791A1
(de)
|
2008-03-31 |
2009-10-07 |
Biotempt B.V. |
Glutamin oder Glutamine enthaltendes Dipeptide in einer spezifischen Dosierung für die Behandlung von Entzündungen
|
US8198344B2
(en)
*
|
2008-06-20 |
2012-06-12 |
Adhezion Biomedical, Llc |
Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
|
US8293838B2
(en)
*
|
2008-06-20 |
2012-10-23 |
Adhezion Biomedical, Llc |
Stable and sterile tissue adhesive composition with a controlled high viscosity
|
US9254133B2
(en)
|
2008-10-31 |
2016-02-09 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
US8609128B2
(en)
*
|
2008-10-31 |
2013-12-17 |
Adhezion Biomedical, Llc |
Cyanoacrylate-based liquid microbial sealant drape
|
US8652510B2
(en)
|
2008-10-31 |
2014-02-18 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
WO2010080452A2
(en)
|
2008-12-18 |
2010-07-15 |
Quark Pharmaceuticals, Inc. |
siRNA COMPOUNDS AND METHODS OF USE THEREOF
|
US9149509B2
(en)
|
2009-03-26 |
2015-10-06 |
Henry Ford Health System |
Methods for improving neurological outcome after neural injury and neurodegenerative disease
|
CN102458418B
(zh)
|
2009-06-08 |
2015-09-16 |
夸克制药公司 |
一种寡核苷酸化合物的制药用途
|
AU2010324658A1
(en)
|
2009-11-26 |
2012-05-03 |
Quark Pharmaceuticals, Inc. |
siRNA compounds comprising terminal substitutions
|
AU2010328104B2
(en)
|
2009-12-09 |
2014-10-30 |
Nitto Denko Corporation |
Modulation of hsp47 expression
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
JP2013520444A
(ja)
|
2010-02-22 |
2013-06-06 |
ヘルス エンハンスメント プロダクツ インコーポレイテッド |
高コレステロール血症を処置するための薬剤及び機序
|
US9309019B2
(en)
|
2010-05-21 |
2016-04-12 |
Adhezion Biomedical, Llc |
Low dose gamma sterilization of liquid adhesives
|
CA2801928C
(en)
|
2010-06-24 |
2018-04-10 |
Quark Pharmaceuticals, Inc. |
Double stranded rna compounds to rhoa and use thereof
|
US20140134231A1
(en)
|
2010-10-11 |
2014-05-15 |
Sanford-Burnham Medical Research Institute |
Mir-211 expression and related pathways in human melanoma
|
EP2649181B1
(de)
|
2010-12-06 |
2016-04-27 |
Quark Pharmaceuticals, Inc. |
Doppelsträngige oligonukleotidverbindungen mit positionsmodifikationen
|
AU2012223366B2
(en)
|
2011-03-03 |
2017-02-23 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
WO2012118910A2
(en)
|
2011-03-03 |
2012-09-07 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating lung disease and injury
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
WO2013070821A1
(en)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
SG11201403756PA
(en)
|
2012-01-01 |
2014-11-27 |
Qbi Entpr Ltd |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
US20140364484A1
(en)
|
2012-01-12 |
2014-12-11 |
Quark Pharmaceuticals, Inc. |
Combination therapy for treating hearing and balance disorders
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
HUE032613T2
(en)
|
2012-06-04 |
2017-10-30 |
Diamedica Therapeutics Inc |
Human tissue kallikrein 1 is glycosylated isoforms
|
PT2864360T
(pt)
|
2012-06-25 |
2018-01-05 |
The Brigham And Women`S Hospital Inc |
Terapêuticas dirigidas ao alvo
|
JP6364009B2
(ja)
|
2012-09-12 |
2018-07-25 |
クォーク ファーマシューティカルズ インコーポレーティッドQuark Pharmaceuticals,Inc. |
P53に対する二本鎖オリゴヌクレオチド分子、およびその使用方法
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
ES2704855T3
(es)
|
2012-09-12 |
2019-03-20 |
Quark Pharmaceuticals Inc |
Moléculas de oligonucleótido de doble cadena para p53 y métodos de uso de las mismas
|
JP6154025B2
(ja)
|
2012-12-24 |
2017-06-28 |
ニューロガストルクス,インコーポレイテッド |
Gi管障害を治療するための方法
|
KR20160029731A
(ko)
|
2013-03-12 |
2016-03-15 |
더 제너럴 하스피탈 코포레이션 |
변형된 뮐러관 억제 물질(mis) 단백질 및 질환 치료를 위한 그 용도
|
US9539265B2
(en)
|
2013-03-15 |
2017-01-10 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
WO2014142938A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
US10232028B2
(en)
|
2013-06-13 |
2019-03-19 |
Zivo Bioscience, Inc. |
Compounds and methods for affecting cytokines
|
WO2015020960A1
(en)
|
2013-08-09 |
2015-02-12 |
Novartis Ag |
Novel lncrna polynucleotides
|
EP3079712B1
(de)
|
2013-12-11 |
2022-02-02 |
The General Hospital Corporation |
Verwendung von anti-müller-hormon (amh)-proteine zur kontrazeption und ovariellen reservekonservierung
|
US9421297B2
(en)
|
2014-04-02 |
2016-08-23 |
Adhezion Biomedical, Llc |
Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
|
US9844554B2
(en)
|
2014-06-24 |
2017-12-19 |
Neurogastrx, Inc. |
Prodrugs of metopimazine
|
PL3258948T3
(pl)
|
2015-02-16 |
2024-04-22 |
Zivo Bioscience, Inc. |
Kompozycje przeciwzapalne i immunomodulujące zawierające klebsormidium i ich zastosowania
|
EP3416501A4
(de)
|
2016-02-16 |
2019-11-20 |
Zivo Bioscience, Inc. |
Ernährungsunterstützung für tiere durch verabreichung eines aus algen gewonnenen nahrungsergänzungsmittels
|
AU2018230478A1
(en)
|
2017-03-09 |
2019-09-12 |
Diamedica Inc. |
Dosage forms of tissue kallikrein 1
|
US10836757B1
(en)
|
2020-04-02 |
2020-11-17 |
Neurogastrx, Inc. |
Polymorphic forms of metopimazine
|
EP3922720A1
(de)
|
2020-06-09 |
2021-12-15 |
Universidad de Murcia |
Therapie zur verhinderung unerwünschter kardialer remodellierung nach einem akuten myokardinfarkt
|
US20220265582A1
(en)
|
2021-02-24 |
2022-08-25 |
Universitätsspital Basel |
Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
|
US11801256B2
(en)
|
2021-06-08 |
2023-10-31 |
Universitätsspital Basel |
Antidepressant-psilocybin co-treatment to assist psychotherapy
|